Novartis (Spain)

326 papers and 8.2k indexed citations i.

About

In recent decades, authors affiliated with Novartis (Spain) have published 326 papers, which have received a total of 8.2k indexed citations. Scholars at this organization have produced 59 papers in Pulmonary and Respiratory Medicine, 56 papers in Physiology and 43 papers in Immunology on the topics of Asthma and respiratory diseases (34 papers), Psoriasis: Treatment and Pathogenesis (32 papers) and Health Systems, Economic Evaluations, Quality of Life (23 papers). Their work is cited by papers focused on Molecular Biology (1.4k citations), Physiology (1.1k citations) and Pulmonary and Respiratory Medicine (1.1k citations). Authors at Novartis (Spain) collaborate with scholars in Spain, United States and Switzerland and have published in prestigious journals including The Lancet, Circulation and Journal of Clinical Oncology. Some of Novartis (Spain)'s most productive authors include Joan Fortuny, Xavier Badı́a, Marietta Rottenkolber, Joerg Hasford and Mercedes Cucala.

In The Last Decade

Fields of papers published by authors at Novartis (Spain)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Novartis (Spain) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Novartis (Spain)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novartis (Spain). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (Spain) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (Spain) more than expected).

Rankless by CCL
2025